Ameritas Investment Partners, Inc. Cue Biopharma, Inc. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$3.11 - $4.91 $8,875 - $14,013	2,854 New	2,854 $10,000
Q2 2022 Aug 12, 2022	SELL	$2.49 - $5.92 $6,100 - $14,504	-2,450 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$12.7 - $30.73 $11,099 - $26,858	874 Added 55.46%	2,450 $60,000
Q2 2018 Aug 13, 2018	BUY	$10.93 - $14.48 $9,006 - $11,931	824 Added 109.57%	1,576 $19,000
Q1 2018 May 15, 2018	BUY	$11.63 - $17.25 $8,745 - $12,972	752 New	752 $11,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.